Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP753913.RAOqnAD-bZWm6PbOzk48WVXGatH2dQJqV5kxnCAPi217Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP753913.RAOqnAD-bZWm6PbOzk48WVXGatH2dQJqV5kxnCAPi217Y130_assertion type Assertion NP753913.RAOqnAD-bZWm6PbOzk48WVXGatH2dQJqV5kxnCAPi217Y130_head.
- NP753913.RAOqnAD-bZWm6PbOzk48WVXGatH2dQJqV5kxnCAPi217Y130_assertion description "[Although the cytomorphologic features alone were not specific, the presence of a markedly elevated serum lipase level, cutaneous lesions of fat necrosis, and loss of heterozygosity at 1p, 5q25 at the APC locus, 9p21 at the p16 locus, and 17p13 at the p53 locus were essential in excluding the main differential diagnostic entities including pancreatic ductal carcinoma, pancreatic endocrine tumor, and pancreatoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP753913.RAOqnAD-bZWm6PbOzk48WVXGatH2dQJqV5kxnCAPi217Y130_provenance.
- NP753913.RAOqnAD-bZWm6PbOzk48WVXGatH2dQJqV5kxnCAPi217Y130_assertion evidence source_evidence_literature NP753913.RAOqnAD-bZWm6PbOzk48WVXGatH2dQJqV5kxnCAPi217Y130_provenance.
- NP753913.RAOqnAD-bZWm6PbOzk48WVXGatH2dQJqV5kxnCAPi217Y130_assertion SIO_000772 12112815 NP753913.RAOqnAD-bZWm6PbOzk48WVXGatH2dQJqV5kxnCAPi217Y130_provenance.
- NP753913.RAOqnAD-bZWm6PbOzk48WVXGatH2dQJqV5kxnCAPi217Y130_assertion wasDerivedFrom befree-20150227 NP753913.RAOqnAD-bZWm6PbOzk48WVXGatH2dQJqV5kxnCAPi217Y130_provenance.
- NP753913.RAOqnAD-bZWm6PbOzk48WVXGatH2dQJqV5kxnCAPi217Y130_assertion wasGeneratedBy ECO_0000203 NP753913.RAOqnAD-bZWm6PbOzk48WVXGatH2dQJqV5kxnCAPi217Y130_provenance.